Search research articles
Contact Us
Filters
Showing results (221-230 of 238) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2026
Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma
Nurit Gal-Mark, Assaf Grunwald, Valid Gahramanov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study
Esther R Berko, Arlene Naranjo, Alexander A Daniels, et al.
Bulletin of Experimental Biology and Medicine
|
November 29, 2019
Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus
O V Kornyushin, D L Sonin, Ya G Toropova, et al.
Cancer Research Communications
|
November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma
Kateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
BMC Medicine
|
August 5, 2015
The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?
Perianayagam Arokiasamy, Uttamacharya Uttamacharya, Kshipra Jain, et al.
Journal of Medical Genetics
|
July 9, 2016
De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia
Esther R Berko, Megan T Cho, Christine Eng, et al.
Molecular Cancer Therapeutics
|
February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma
Smita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Infectious Diseases of Poverty
|
August 16, 2023
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Kenneth Bentum Otabil, Blessing Ankrah, Emmanuel John Bart-Plange, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 30, 2025
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
Inge M W Verberk, Mariam Gouda, Daniel Antwi-Berko, et al.
Nature Communications
|
May 5, 2023
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
Esther R Berko, Gabriela M Witek, Smita Matkar, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 238) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2026
Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma
Nurit Gal-Mark, Assaf Grunwald, Valid Gahramanov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study
Esther R Berko, Arlene Naranjo, Alexander A Daniels, et al.
Bulletin of Experimental Biology and Medicine
|
November 29, 2019
Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus
O V Kornyushin, D L Sonin, Ya G Toropova, et al.
Cancer Research Communications
|
November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma
Kateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
BMC Medicine
|
August 5, 2015
The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?
Perianayagam Arokiasamy, Uttamacharya Uttamacharya, Kshipra Jain, et al.
Journal of Medical Genetics
|
July 9, 2016
De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia
Esther R Berko, Megan T Cho, Christine Eng, et al.
Molecular Cancer Therapeutics
|
February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma
Smita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Infectious Diseases of Poverty
|
August 16, 2023
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Kenneth Bentum Otabil, Blessing Ankrah, Emmanuel John Bart-Plange, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 30, 2025
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
Inge M W Verberk, Mariam Gouda, Daniel Antwi-Berko, et al.
Nature Communications
|
May 5, 2023
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
Esther R Berko, Gabriela M Witek, Smita Matkar, et al.
Page
of 24